Gf Fund Management Co. Ltd.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-29
Total Holdings
666
Total Value
4262829836
Accession Number
0002057060-25-000003
Form Type
13F-HR
Manager Name
Gf Fund Management Co. Ltd.
Data Enrichment
99% identified
658 identified8 unidentified

Holdings

666 positions
Manager:
Search and click to pin securities to the top
Page 29 of 34
590717401
Shares:
817(+21.8%)
Value:
$10.2M(-23.3%)
UNIVERSAL HEALTH REALTY INCOME TRUST
Shares:
247(+4.2%)
Value:
$10.1M(+14.7%)
Oric Pharmaceuticals, Inc.
Shares:
1807(+21.9%)
Value:
$10.1M(-15.7%)
SIGA TECHNOLOGIES INC
Shares:
1828(+21.9%)
Value:
$10.0M(+11.2%)
Tourmaline Bio, Inc.
Shares:
656(+21.9%)
Value:
$10.0M(-8.6%)
Erasca, Inc.
Shares:
7240(+22.0%)
Value:
$9.9M(-33.4%)
Verve Therapeutics, Inc.
Shares:
2167(+21.9%)
Value:
$9.9M(-1.2%)
Sana Biotechnology, Inc.
Shares:
5716(+21.9%)
Value:
$9.6M(+25.7%)
CorMedix Inc.
Shares:
1554(+22.0%)
Value:
$9.6M(-7.2%)
Community Healthcare Trust Inc
Shares:
527(+4.2%)
Value:
$9.6M(-1.5%)
Farmland Partners Inc.
Shares:
858(+4.0%)
Value:
$9.6M(-1.4%)
BICYCLE THERAPEUTICS PLC
Shares:
1126(+21.9%)
Value:
$9.6M(-26.1%)
EyePoint Pharmaceuticals, Inc.
Shares:
1747(+21.9%)
Value:
$9.5M(-11.3%)
Rapport Therapeutics, Inc.
Shares:
936(+21.9%)
Value:
$9.4M(-31.1%)
ALEXANDERS INC
Shares:
44(+7.3%)
Value:
$9.2M(+12.2%)
Oruka Therapeutics, Inc.
Shares:
896(+21.9%)
Value:
$9.2M(-35.5%)
Altimmune, Inc.
Shares:
1821(+22.0%)
Value:
$9.1M(-15.4%)
REGENXBIO Inc.
Shares:
1269(+22.0%)
Value:
$9.1M(+12.9%)
SAUL CENTERS, INC.
Shares:
250(+4.6%)
Value:
$9.0M(-2.7%)
Stoke Therapeutics, Inc.
Shares:
1355(+21.9%)
Value:
$9.0M(-26.5%)